Global Mobile Health (mHealth) & mHealth Apps Market (North America - The US; Europe - Germany; Asia Pacific - Japan, China & India) Outlook 2022

  • ID: 4586277
  • Report
  • Region: Global, Asia, Asia Pacific, Europe, North America, China, Germany, India, Japan, United States
  • 82 Pages
  • Rockville Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • MORE

Worldwide healthcare is progressively moving towards precision based model which is largely predictive, personalized, participatory and preventive. Ubiquity of mobile technology and various long withstanding issues in healthcare domain has made mobile health inevitable. Medical health apps are being hailed as the next big revolution in healthcare arena. It is increasingly replacing sedentary healthcare techniques. Moreover, its usability in diverse areas such as chronic care management, healthcare and fitness, medication management, personal health record apps, etc. has further strengthened its market position.

Global medical health apps market is already progressing at leaps and bounds and is expected to witness spectacular growth in the upcoming years. Growth of the market is primarily attributed to higher adoption of smartphones, growing internet penetration, better health management associated with use of mHealth apps and cost effectiveness. However, factors restraining growth of the industry includes behavioral barriers with adoption of mHealth apps, reimbursement issues, lack of standardization and interoperability in the industry and security risks.

The report “Global Mobile Health (mHealth) & mHealth Apps Market (North America-The US; Europe-Germany; Asia Pacific-Japan, China & India) Outlook 2022” provides information on the current scenario, detailed market outlook of the global mobile health market with detailed analysis of mobile health apps across regions such as North America (The US), Asia Pacific (China, Japan & India) & European (Germany) market.  Future forecasts of mHealth market overall and mHealth Apps market till 2022, for all the geographies is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the market includes Abbott Laboratories, Johnson & Johnson, AstraZeneca plc, Novartis AG, and Pfizer Inc. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional mobile health apps market.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • MORE

1. Executive Summary

2. Research Methodology

3. mHealth
3.1 Introduction
3.1.1 Overview
3.1.2 Business Models
3.1.3 Application Areas
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by End-Use
3.2.3 Market Share by Region

4. mHealth Apps
4.1 Introduction
4.1.1 Overview
4.1.2 Segmentation
4.1.3 mHealth Value Chain Analysis

5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.1.1 Market Sizing by Value (Actual & Forecasted)
5.1.2 Market Sizing by Volume (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Type
5.2.2 Market Share by Platform
5.2.3 Market Share by End-User
5.2.5 Market Share by Distribution Channel
5.2.6 Market Share by Region

6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Size by Value (Actual & Forecasted)
6.1.2.2 Market Size by Volume (Actual & Forecasted)
6.1.2.3 Market Share by Distribution Channel
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Size by Value (Actual & Forecasted)
6.2.2.2 Market Size by Volume (Actual & Forecasted)
6.2.2.3 Market Share by App Type
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Nations
6.3.3 Japan
6.3.3.1 Market Size by Value (Actual & Forecasted)
6.3.3.2 Market Size by Volume (Actual & Forecasted)
6.3.4 China
6.3.4.1 Market Size by Value (Actual & Forecasted)
6.3.4.2 Market Size by Volume (Actual & Forecasted)
6.3.5 India
6.3.5.1 Market Size by Value (Actual & Forecasted)
6.3.5.2 Market Size by Volume (Actual & Forecasted)

7. Market Dynamics
7.1 Industrial Trends & Developments
7.1.1 Apps for Different Healthcare Segments
7.1.2 Mergers & Acquisitions
7.2 Growth Drivers
7.2.1 Higher Adoption of Smartphones
7.2.2 Growing Internet Penetration
7.2.3 Better Health Management
7.2.4 Cost Effective
7.3 Challenges
7.3.1 Behavioral Barriers
7.3.2 Reimbursement Issues
7.3.3 Lack of Standardization and Interoperability
7.3.4 Security Risks

8. Competitive Landscape

9. Company Profiles
9.1 Abbott Laboratories
9.2 Johnson & Johnson
9.3 Novartis International AG
9.4 AstraZeneca plc
9.5 Pfizer Inc.

List of Figures & Tables
Figure 1: Research Methodology
Figure 2: Global Mobile Health Market Size by Value, 2012-22E (US$ Billions)
Figure 3: Global mHealth Market Share by End-Use (2017)
Figure 4: Global Mobile Health Market Share by Region (2017)
Figure 5: mHealth Value Chain Analysis
Figure 6: Global mHealth Apps Market Size by Value, 2013-22E (US$ Billions)
Figure 7: Global mHealth Apps Market Size by Volume, 2013-22E (Billions)
Figure 8: Global mHealth Apps Market Share by Type (2017)
Figure 9: Global mHealth Market Share by Platform (2017)
Figure 10: Global mHealth Apps Market Share by End-User (2017)
Figure 11: Global mHealth App Market Share by Distribution Channel (2017)
Figure 12: Global mHealth Apps Market Share by Region (2017)
Figure 13: North America Mobile Health Apps Market Size by Value, 2015-22E (US$ Billions)
Figure 14: The US Mobile Health Apps Market Size by Value, 2013-22E (US$ Millions)
Figure 15: The US Mobile Health Apps Market Size by Volume, 2013-22E (Millions)
Figure 16: The US mHealth Apps Market Share by Distribution Channel (2017)
Figure 17: Europe Mobile Health Apps Market Size by Value, 2015-22E (US$ Billions)
Figure 18: Germany Mobile Health Apps Market Size by Value, 2015-22E (US$ Millions)
Figure 19: Germany Mobile Health Apps Market Size by Volume, 2015-22E (Millions)
Figure 20: Germany Mobile Health Apps Market Share by App Type (2017)
Figure 21: Asia Pacific Mobile Health Apps Market Size by Value, 2015-22E (US$ Billions)
Figure 22: Asia Pacific Mobile Health Market Share by Nations (2017)
Figure 23: Japan Mobile Health Apps Market Size by Value, 2015-22E (US$ Millions)
Figure 24: Japan Mobile Health Apps Market Size by Volume, 2015-22E (Millions)
Figure 25: China Mobile Health Apps Market Size by Value, 2015-22E (US$ Millions)
Figure 26: China Mobile Health Apps Market Size by Volume, 2015-22E (Millions)
Figure 27: India Mobile Health Apps Market Size by Value, 2015-22E (US$ Millions)
Figure 28: India Mobile Health Apps Market Size by Volume, 2015-22E (Millions)
Table 1: mHealth Apps by Healthcare Segments
Table 2: Leading Transactions in mHealth Apps Market
Figure 29: Global Smartphone Market Size, 2012-18E (US$ Billion)
Figure 30: Internet Penetration by Nations (2017)
Table 3: Top mHealth Apps Downloaded Worldwide
Table 4: Financial Analysis of Leading mHealth Apps Developers
Table 5: Abbott Laboratories Mobile Health Apps
Figure 31: Abbott Laboratories Net Sales, FY2013-2017 (US$ Billions)
Table 6: Johnson& Johnson Mobile Health Apps
Figure 32: Johnson & Johnson Net Sales, FY2013-2017 (US$ Billions)
Table 7: Novartis International AG Mobile Health Apps
Figure 33: Novartis International AG Net Sales, FY2013-2017 (US$ Billions)
Table 8: AstraZeneca plc Mobile Health Apps
Figure 34: AstraZeneca plc AG Net Sales, FY2013-2017 (US$ Billions)
Table 9: Pfizer Inc. Mobile Health Apps
Figure 35: Pfizer Inc. Net Sales, FY2013-FY2017 (US$ Billions)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Johnson & Johnson
  • AstraZeneca plc
  • Novartis AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll